Targeting Q1 2026 Launch, Subject to FDA Clearance Key Highlights: Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale ...
Modular Medical (Nasdaq:MODD) announced that it started the production of validation lots for its Pivot tubeless.
SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Modular Medical, Inc. (MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion ...
"The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch pump experience to those who want a simple pump to manage the treatment of diabetes," commented ...
Targeting Q1 2026 Launch, Subject to FDA ClearanceKey Highlights:Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale ...
Submission delayed by U.S. government shutdown; initial FDA questions expected during Q4 2025 "The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results